IHS Chemical Week

Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients

PCI Synthesis: Increased regulatory scrutiny, wage inflations in India and China to impact industry in 2014

7:35 AM MST | December 10, 2013 | Deepti Ramesh

PCI Synthesis (Newburyport, MA), a manufacturer of new chemical entities, generic active pharmaceutical ingredients (APIs), complex pharmaceutical intermediates, and other specialty chemical products, has announced a list of trends that are likely to impact the generic drug and emerging biotech industries in 2014. The trends include increased regulatory scrutiny, drug shortages, wage inflations in India and China, a biotech bubble, and the challenge of finding qualified people. FDA—most recently with a bill signed into law in November 2013, the Drug Quality...

This information is only available to Chemical Week subscribers.

Username:
Password:

Forgot your user ID or password?
Click here to have it sent to you.



Not an IHS Chemical Week member yet?

Here's why you should be:

  • 31 issues of Chemical Week magazine in print or digital format
  • Critical daily news and analysis on chemweek.com
  • Free mobile edition 
  • 20+ years of online archives
  • Topical e-newsletters that capture the most impactful events
  • Special issues with a regional or company focus
  • Global Outlook issue

Subscribe now

100% Satisfaction Guarantee
If at any time you are not completely satisfied with IHS Chemical Week, simply notify us and we'll refund the balance of your paid subscription - no problem.

Learn more about group subscriptions and site licenses.

 














 
contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2015 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa